Inspiremd, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
CEO Marvin Slosman files a Schedule 13D reporting beneficial ownership of 5.18% of InspireMD, Inc. common stock.
NASDAQ
InspireMD's CFO, Michael A. Lawless, reports beneficial ownership of 8.6% of common stock, including new equity grants and voting control over employee shares.
NASDAQ
Craig Shore, a citizen of Israel and the United States, has filed an amendment to his Schedule 13D, reporting beneficial ownership of 3.5% of InspireMD, Inc.'s common stock.